Alnylam Pharmaceuticals Inc · News · TradingHolo

Alnylam Pharmaceuticals Inc · News · TradingHolo

ALNY news

Headlines tagged to this company

RNAi drug developer City climbs after upsized IPO

Seeking Alpha · 3 d ago

RNAi drugmaker City prices upsized IPO at $18 per share

Seeking Alpha · 3 d ago

Alnylam Pharmaceuticals Price Target Cut to $354.00/Share From $550.00 by UBS

Dow Jones Newswires · 4 d ago

Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results

BusinessWire · 4 d ago

Alnylam Pharmaceuticals Price Target Cut to $320.00/Share From $340.00 by Citigroup

Dow Jones Newswires · 5 d ago

Alnylam Pharmaceuticals Price Target Cut to $253.00/Share From $256.00 by Wells Fargo

Dow Jones Newswires · 5 d ago

Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3

Seeking Alpha · 6 d ago

Alnylam Pharmaceuticals Price Target Cut to $345.00/Share From $350.00 by RBC Capital

Dow Jones Newswires · 11 d ago

Alnylam Pharmaceuticals Price Target Cut to $369.00/Share From $375.00 by JP Morgan

Dow Jones Newswires · 19 d ago

10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades

seekingalpha · 31 d ago

4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects

zacks · 48 d ago

ALNY SHAREHOLDER ALERT: Alnylam Pharmaceuticals, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

GuruFocus · 61 d ago

ALNY SHAREHOLDER ALERT: Alnylam Pharmaceuticals, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Business Wire · 61 d ago

Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

GlobeNewsWire · 61 d ago

Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

GuruFocus · 64 d ago

Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

PRNewsWire · 64 d ago

Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing

The Motley Fool · 65 d ago

Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

GlobeNewsWire · 65 d ago

NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

Business Wire · 66 d ago

Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

GlobeNewsWire · 67 d ago